Trump administration’s embattled FDA vaccine chief ousted for the second time
AI Summary
Dr. Vinay Prasad, the FDA's vaccine chief, is leaving the agency for the second time in under a year, as announced by FDA commissioner Marty Makary. Prasad will return to his academic position at the University of California, San Francisco, at the end of April. His departure follows controversies surrounding the FDA's review of vaccines, gene therapies, and biotech drugs, with companies criticizing the agency for reversing decisions. Prasad, a known critic of FDA drug review standards, had previously been ousted in July before being reinstated with support from Robert F Kennedy Jr. and Makary. Since joining the FDA last May, Prasad has both advocated for faster drug reviews and imposed stricter requirements on certain drugs and vaccines, particularly COVID-19 shots.
Key Entities & Roles
Keywords
Sentiment Analysis
Source Transparency
This article was automatically classified using rule-based analysis. The political bias score ranges from -1 (far left) to +1 (far right).
Topic Connections
Explore how the topics in this article connect to other news stories